CAS NO: | 21416-67-1 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | Razoxane (ICRF 159) is an antiangiogenictopoisomeraseIIinhibitor, can be used for the research of renal cell carcinoma (RCC)[1]. | ||||||||
IC50& Target[1] |
| ||||||||
体外研究 (In Vitro) | Razoxane (30 mg/kg; i.p.) exhibits antimetastatic effects in a rat osteosarcoma model. | ||||||||
体内研究 (In Vivo) | Early treatment with Razoxane (30 mg/kg i.p. from day -2 to +14) shows a greater inhibition of pulmonary metastases than later treatment (30 mg/kg i.p. from day +14 to +28 after transplantation)[2].
| ||||||||
分子量 | 268.27 | ||||||||
Formula | C11H16N4O4 | ||||||||
CAS 号 | 21416-67-1 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |